The drug business is good, even forinvestors. (Photo: Getty)
(Bloomberg) –A boom in major U.S. pharmaceutical stocks iscreating a swarm of activity around an exchange-traded fundtracking the massive drugmakers.
The $8.2 billion Vanguard Health Care ETF, known by its tickerVHT, had 1.6 million shares worth $272 million trade Monday, recordone-day turnover for the fund. It also hasn't seen a day ofoutflows in August, with $145 million of net inflows putting theETF on track for its best month since June 2017.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
